当前位置:首页 - 行情中心 - 百诚医药(301096) - 财务分析

百诚医药

(301096)

  

流通市值:24.29亿  总市值:38.21亿
流通股本:6943.03万   总股本:1.09亿

百诚医药(301096)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-0.26亿元,每股收益-0.24元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益255315.98万元,未分配利润33267.79万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产377388.59万元,负债122072.61万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入128,727,480.49801,923,244.22721,478,652.99525,061,535.12
营业总成本164,765,613.68809,886,835.1580,693,571.16384,876,280.34
营业利润-27,913,185.92-34,393,587.84130,833,977.21133,944,633.77
利润总额-27,784,050.64-36,060,972.55130,715,405.62134,108,337.23
净利润-26,197,617.81-52,922,991.09141,537,618.64134,171,505.31
其他综合收益-32,349.31-6,882.642,248.55-507.93
综合收益总额-26,229,967.12-52,929,873.73141,539,867.19134,170,997.38
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,610,431,297.781,545,474,358.291,591,071,868.791,734,845,327.93
非流动资产合计2,163,454,579.032,175,714,157.212,168,831,814.192,177,781,237.2
资产总计3,773,885,876.813,721,188,515.53,759,903,682.983,912,626,565.13
流动负债合计846,593,327.09769,379,232.56821,900,623.85941,860,218.56
非流动负债合计374,132,732.56372,419,498.66167,899,305.37170,072,791.22
负债合计1,220,726,059.651,141,798,731.22989,799,929.221,111,933,009.78
归属于母公司股东权益合计2,553,159,817.162,579,389,784.282,769,732,268.462,800,242,564.22
股东权益合计2,553,159,817.162,579,389,784.282,770,103,753.762,800,693,555.35
负债和股东权益合计3,773,885,876.813,721,188,515.53,759,903,682.983,912,626,565.13
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计108,725,148.09652,039,793.93476,014,362.72338,993,186.31
经营活动现金流出小计178,755,029.29847,896,719.57659,069,923.64433,881,402.3
经营活动产生的现金流量净额-70,029,881.2-195,856,925.64-183,055,560.92-94,888,215.99
投资活动现金流入小计128,032,273.42472,533,753.97205,598,029.65117,984,601.53
投资活动现金流出小计216,818,178.62937,071,213.72769,026,433.85500,667,184.36
投资活动产生的现金流量净额-88,785,905.2-464,537,459.75-563,428,404.2-382,682,582.83
筹资活动现金流入小计200,000,0001,253,720,662.98673,783,342.98654,890,000
筹资活动现金流出小计84,345,847.91955,630,611.49480,411,888.06390,135,858.39
筹资活动产生的现金流量净额115,654,152.09298,090,051.49193,371,454.92264,754,141.61
汇率变动对现金及现金等价物的影响-30,408.9112,965.021,720.59-452.59
现金及现金等价物净增加额-43,192,043.22-362,291,368.88-553,110,789.61-212,817,109.8
期末现金及现金等价物余额372,969,302.84416,161,346.06225,341,925.33565,635,605.14
最新报告期:2025-04-27
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西部证券李梦园0.500.951.092025-04-27
太平洋周豫0.960.981.142025-04-23
TOP↑